By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Promedior 

5 Great Valley Parkway
Suite 300
Malvern  Pennsylvania  19355  U.S.A.
Phone: 610-560-1435 Fax: 610-560-1436


SEARCH JOBS








Company News
Promedior Announces Presentation Of Interim Phase 2 Data On PRM-151 In Myelofibrosis At The Upcoming Congress Of European Hematology Association 6/5/2014 7:41:29 AM
Tiny Promedior To Present Positive Phase 2 Myelofibrosis Data Next Week 5/30/2014 6:42:10 AM
Promedior Announces Presentation Of Interim Phase 2 Data On PRM-151 In Myelofibrosis At American Society of Clinical Oncology 5/15/2014 9:14:04 AM
Promedior Attains Patient Enrollment Milestone In Phase 2 Clinical Study Of PRM-151 In Myelofibrosis 1/8/2014 9:04:09 AM
Promedior Initiates Phase 2 Clinical Study of PRM-151 in Myelofibrosis 10/9/2013 9:54:21 AM
Promedior Adds Howard J. Weisman to Board of Directors 6/19/2013 7:38:35 AM
Promedior Presents Encouraging Results From Clinical Study of PRM-151 in Patients With Idiopathic Pulmonary Fibrosis 5/23/2013 8:43:04 AM
Promedior to Present Clinical Data on Lead Drug Candidate, PRM-151, in Patients With IPF at the ATS 2013 Annual Meeting 5/16/2013 11:20:26 AM
Promedior to Present Clinical Data on Lead Drug Candidate, PRM-151, in Patients With IPF at the American Thoracic Society 2013 Annual Meeting 5/16/2013 11:00:42 AM
Promedior to Present Clinical Data on Lead Drug Candidate, PRM-151, in Patients with IPF at the ATS 2013 Annual Meeting 5/16/2013 10:14:08 AM
1234
//-->